Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

9431 ARTÍCULOS , VIENDO DEL 7096 AL 7110

Zuclopenthixol acetate for acute schizophrenia and similar serious mental illnesses

Jayakody K, Gibson RC, Kumar A, Gunadasa S.

Cochrane Database Syst Rev. 2012 Apr 18;2012(4):CD000525. doi: 10.1002/14651858.CD000525.pub3.

Pantothenate kinase-associated neurodegeneration

Hartig MB, Prokisch H, Meitinger T, Klopstock T.

Curr Drug Targets. 2012 Aug;13(9):1182-9. doi: 10.2174/138945012802002384.

Clozapine-induced stuttering: a case report and analysis of similar case reports in the literature

Grover S, Verma AK, Nebhinani N.

Gen Hosp Psychiatry. 2012 Nov-Dec;34(6):703.e1-3. doi: 10.1016/j.genhosppsych.2012.02.010. Epub 2012 Apr 18.

Psychosis from a bath salt product containing flephedrone and MDPV with serum, urine, and product quantification

Thornton SL, Gerona RR, Tomaszewski CA.

J Med Toxicol. 2012 Sep;8(3):310-3. doi: 10.1007/s13181-012-0232-4.

The psychopharmacological management of RLS in psychiatric conditions: a review of the literature

Cuellar NG.

J Am Psychiatr Nurses Assoc. 2012 Jul-Aug;18(4):214-25. doi: 10.1177/1078390312442569. Epub 2012 Apr 22.

Difficult differential diagnosis of Unverricht-Lundborg disease with spontaneous kinesogenic myoclonus and movement disorder

Rana AQ, Ali A, Böke BN.

Acta Neurol Belg. 2012 Dec;112(4):383-4. doi: 10.1007/s13760-012-0075-4. Epub 2012 Apr 27.

Comparison of surgical intervention with functional treatment for acute ruptures of lateral ankle ligmant: a meta-analysis

Hao ZT, Ma YX, Hao T, Feng W, Wang JH, Fan DS, Wen SZ.

Asian Pac J Trop Med. 2012 May;5(5):396-401. doi: 10.1016/S1995-7645(12)60066-2.

Movement disorder in ataxia-telangiectasia: treatment with amantadine sulfate

Nissenkorn A, Hassin-Baer S, Lerman SF, Levi YB, Tzadok M, Ben-Zeev B.

J Child Neurol. 2013 Feb;28(2):155-60. doi: 10.1177/0883073812441999. Epub 2012 May 1.

Movement disorders in autoimmune diseases

Baizabal-Carvallo JF, Jankovic J.

Mov Disord. 2012 Jul;27(8):935-46. doi: 10.1002/mds.25011. Epub 2012 May 3.

Antipsychotic drugs versus placebo for relapse prevention in schizophrenia: a systematic review and meta-analysis

Leucht S, Tardy M, Komossa K, Heres S, Kissling W, Salanti G, Davis JM.

Lancet. 2012 Jun 2;379(9831):2063-71. doi: 10.1016/S0140-6736(12)60239-6. Epub 2012 May 3.

Placebo-controlled trial of lubiprostone for constipation associated with Parkinson disease

Ondo WG, Kenney C, Sullivan K, Davidson A, Hunter C, Jahan I, McCombs A, Miller A, Zesiewicz TA.

Neurology. 2012 May 22;78(21):1650-4. doi: 10.1212/WNL.0b013e3182574f28. Epub 2012 May 9.

Clinical Inquiry. What drugs are effective for periodic limb movement disorder?

Lee YA, Huynh P, Neher JO, Safranek S.

J Fam Pract. 2012 May;61(5):296-8.

What's the role of topiramate in the management of patients with hyperkinetic movement disorders?

Siniscalchi A, Gallelli L, Giofrè C, De Sarro G.

Pharmacol Rep. 2012;64(1):24-30. doi: 10.1016/s1734-1140(12)70727-2.

Maintenance treatment with antipsychotic drugs for schizophrenia

Leucht S, Tardy M, Komossa K, Heres S, Kissling W, Davis JM.

Cochrane Database Syst Rev. 2012 May 16;(5):CD008016. doi: 10.1002/14651858.CD008016.pub2.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias